0001399529-21-000120.txt : 20210617
0001399529-21-000120.hdr.sgml : 20210617
20210617211854
ACCESSION NUMBER: 0001399529-21-000120
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210615
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paglia Regina M.
CENTRAL INDEX KEY: 0001813985
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36281
FILM NUMBER: 211026891
MAIL ADDRESS:
STREET 1: C/O DICERNA PHARMACEUTICALS, INC.
STREET 2: 33 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001399529
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205993609
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617 621 8097
MAIL ADDRESS:
STREET 1: 75 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
wf-form4_162397911311628.xml
FORM 4
X0306
4
2021-06-15
0
0001399529
Dicerna Pharmaceuticals Inc
DRNA
0001813985
Paglia Regina M.
C/O DICERNA PHARMACEUTICALS, INC.
75 HAYDEN AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Human Resources Officer
Common Stock
2021-06-15
4
M
0
381
A
381
D
Common Stock
2021-06-15
4
F
0
112
35.74
D
269
D
Common Stock
2021-06-16
4
M
0
20000
12.93
A
20269
D
Common Stock
2021-06-16
4
M
0
10000
22.58
A
30269
D
Common Stock
2021-06-16
4
M
0
1564
26.62
A
31833
D
Common Stock
2021-06-16
4
S
0
31464
35.6284
D
369
D
Common Stock
2021-06-16
4
S
0
100
36.15
D
269
D
Restricted Stock Units
2021-06-15
4
M
0
381
0
D
Common Stock
381.0
1144
D
Employee Stock Option (Right to Buy)
12.93
2021-06-16
4
M
0
20000
0
D
2029-02-28
Common Stock
20000.0
103414
D
Employee Stock Option (Right to Buy)
22.58
2021-06-16
4
M
0
10000
0
D
2030-01-07
Common Stock
10000.0
52500
D
Employee Stock Option (Right to Buy)
26.62
2021-06-16
4
M
0
1564
0
D
2030-06-30
Common Stock
1564.0
5261
D
Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
The Reporting Person sold an aggregate of 31,564 shares of Common Stock on June 16, 2021 (the "Shares Sold") as reported in this Form 4. The Shares Sold represent 11.35% of 278,052 shares of Common Stock, which is the number of shares of Common Stock owned by the Reporting Person prior to the Shares Sold transaction reported in this Form 4, as well as shares issuable upon exercise or settlement of vested and unvested options and restricted stock units held by the Reporting Person as of the date of this report.
Represents RSUs that vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of June 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer on each applicable vesting date.
The option vested 25% on the first year anniversary of the vesting start date of February 19, 2019 and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject in each case to the Reporting Person's continued service with the Issuer through each applicable vesting date.
The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of January 2020, and the remaining vesting on the last day of each of the 47 months thereafter; subject in each case to the Reporting Person's continued service with the Issuer through each applicable vesting date.
The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of July 2020, and the remaining shares vesting on the last day of each of the 47 months thereafter; subject in each case to the Reporting Person's continued service with the Issuer through the applicable vesting date.
/s/ Douglas W. Pagan, attorney-in-fact
2021-06-17